BioSante Pharmaceuticals (BPAX) announces positive results from a clinical study of its Pancreas...

|By:, SA News Editor

BioSante Pharmaceuticals (BPAX) announces positive results from a clinical study of its Pancreas cancer vaccine indicating that the treatment increases the median survival rate for patients. Shares of BPAX +22.3% premarket.